Inozyme Pharma, Inc. (INZY)
NASDAQ: INZY · Real-Time Price · USD
3.990
-0.010 (-0.25%)
At close: Jun 27, 2025, 4:00 PM
4.000
+0.010 (0.25%)
After-hours: Jun 27, 2025, 7:43 PM EDT
Inozyme Pharma Market Cap
Inozyme Pharma has a market cap or net worth of $259.01 million as of June 27, 2025. Its market cap has decreased by -12.21% in one year.
Market Cap
259.01M
Enterprise Value
221.19M
1-Year Change
-12.21%
Ranking
Category
Stock Price
$3.99
Market Cap Chart
Since July 24, 2020, Inozyme Pharma's market cap has decreased from $356.32M to $259.01M, a decrease of -27.31%. That is a compound annual growth rate of -6.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2025 | 259.66M | 45.92% |
| Dec 31, 2024 | 177.95M | -32.37% |
| Dec 29, 2023 | 263.10M | 520.31% |
| Dec 30, 2022 | 42.41M | -73.72% |
| Dec 31, 2021 | 161.39M | -66.54% |
| Dec 31, 2020 | 482.42M | 35.39% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 711.37B |
| Johnson & Johnson | 366.59B |
| AbbVie | 328.11B |
| Novo Nordisk | 313.40B |
| UnitedHealth Group | 274.06B |
| Abbott Laboratories | 238.81B |
| Novartis AG | 232.39B |
| AstraZeneca | 218.32B |